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Abstract
Background: Increases in urokinase-like plasminogen activator (uPA) activity are reported to be
amongst the earliest events occurring in remnant liver following partial hepatectomy in rats, and
have been proposed as a key component of the regenerative response. Remodelling of the
extracellular matrix, conversion of single chain hepatocyte growth factor to the active two-chain
form and a possible activation of a mitogenic signalling pathway have all been ascribed to the
increased uPA activity. The present study aimed to determine whether similar early increases in
uPA activity could be detected in the remnant liver following resection of metastatic tumours in
surgical patients.
Results: Eighteen patients undergoing partial hepatectomy for the removal of hepatic metastases
secondary to primary colonic tumours were studied. Increased plasminogen activator activity was
found in the final liver samples for the group of patients in whom the resection size was at least
50%. For smaller resections, the increased activity was not observed. The increased activity did not
correlate with the age of the patient or with the time between the start of resection and the end
of the operation. There was, however, a negative correlation between plasminogen activator
activity and the time for which blood supply to the liver was clamped.
Conclusions: Our findings are in accordance with those from experimental animal models and
show, for the first time, that rapid increases in plasminogen activator activity can occur following
similarly large liver resection in humans. Thus, increases in plasminogen activator activity are an
early event in the remnant liver following major liver resection in man. Our observations provide
support for the contention that increases in plasminogen activators play a key role in the initiation
of hepatic regeneration in man.
Background
Urokinase-like plasminogen activator (uPA), initially rec-
ognised by its ability to convert plasminogen to plasmin
and to participate in the fibrinolytic cascade, is now con-
sidered to have a wider role, which encompasses meta-
static invasion by tumour cells and liver regeneration. In
regeneration of the liver following partial hepatectomy,
uPA has a number of potential roles. These include initi-
ating the remodelling of the extracellular matrix to allow
cell division, activation of extra-cellular pro-metallopro-
teases and the release of the bound single-chain form of
hepatocyte growth factor (HGF) from the extracellular
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matrix (ECM). In vitro uPA and tissue-like plasminogen
activator (tPA) have been shown to convert single chain
inactive HGF into the active two chain form [1] in cultures
of hepatocytes. In normal rodent liver, both the inactive
and active forms of HGF can be detected, with the pre-
dominance of the inactive form [2]. Following partial
hepatectomy in the rat there is an early net decrease in the
total amount of HGF in the liver, but the relative propor-
tion of the single chain, inactive form, is decreased and
the active two-chain form increased [2]. This implies an
early proteolytic conversion, possibly mediated by the
plasminogen activators. The importance of the uPA-plas-
minogen system to liver repair has been further demon-
strated by the inability of plasminogen deficient animals
to form regenerative nodules in response to acute liver
injury [3]. As discussed by Mangnall et al. [4], uPA may
also activate a signalling pathway leading to mitosis of the
hepatocyte.
Increases in uPA activity are amongst the earliest docu-
mented changes following partial hepatectomy in rats [5].
Raised uPA activity was detected in the remnant liver at
one-minute post-hepatectomy and continued to increase
for at least one hour, although there were no changes in
the total amount of uPA protein detectable by Western
blotting. The binding of uPA to the uPA receptor (uPAR)
is also associated with an increase in uPA enzymatic activ-
ity [6]. In the rat partial hepatectomy model, the increase
in uPA activity is thought to be due to an increase in the
level of uPAR and subsequent binding and activation of
uPA. In the remnant liver, increases in the amount of
uPAR have been detected by Western blotting also as early
as 1 min post hepatectomy and more clearly at 1 hour.
This had decreased by 6 h and was back to basal levels by
24 h [5]. The mechanism underlying these changes
remains unclear.
Additional support for a role for uPA in the hepatic regen-
erative process comes from studies of uPA-deficient (uPA-
/-) mice. In these animals, uptake of [3H]-thymidine into
DNA and mitotic index were reduced by almost half at 44
h post-hepatectomy (the peak time for control mice), sug-
gesting a slower hepatocyte growth response [7]. In a sep-
arate study uPA-/-mice were treated with anti-Fas
monoclonal antibody to induce extensive hepatocyte
apoptosis. Fas (a member of the TNF-receptor super-
family) is present in the inactive state as a monomer, but
on binding the appropriate ligand (in this case the anti-
body) the receptors aggregate and activate apoptosis lead-
ing to cell destruction. In these uPA-deficient animals, the
regeneration response following anti-Fas treatment was
delayed relative to normal control animals [8]. Genera-
tion of mature HGF and time of peak levels were delayed
in the uPA-/-mice and peak levels of proliferating cell
nuclear antigen at 96 h were also delayed relative to con-
trols, which peaked at 48 h. Treatment of the uPA-/-mice
with the uPA gene by lipofection reversed these effects.
The results support a role for uPA in the generation of
mature HGF and in the regeneration after Fas-mediated
liver damage.
More recently, studies with uPA or plasminogen deficient
mice confirmed the requirement for plasminogen activa-
tion in liver regeneration and also showed a need for plas-
minogen in regeneration-associated hepatic angiogenesis
[9]. Collectively, these studies strongly suggest that a very
early increase in uPA activity is a key feature of the liver
regenerative response in rodents. It is generally assumed
that regeneration in the human liver follows a similar
course but the relative paucity of studies in humans
means that, at present, it is unclear whether a similar role
for uPA exists in the regeneration of human liver.
Though not necessarily identical, it is clear from the liter-
ature that regeneration in humans and rodents share sim-
ilar mechanisms. Many of the cytokines and growth
factors essential for regeneration in rodents [reviewed in
[4]] are also found in increased amounts in the regenerat-
ing human liver, implying once more similar
mechanisms.
However, clear differences between species do exist; a
notable example being the differences in the time at
which DNA synthesis peaks in the remnant liver. In rats,
this is at about 24 h; in mice, at about 40 h; and in man,
at 180–200 h following hepatectomy. In the case of the
human studies, this may partially reflect the relatively
greater age of the patients since the rate of regeneration
slows with age. Such age related effects are less likely in the
rodent studies where the timing of hepatocyte entry into
DNA synthesis following partial hepatectomy has been
shown to be an intrinsic, cell-autonomous, feature [10].
Thus, although the basic mechanisms may be fundamen-
tally similar, there are inherent differences between spe-
cies (such as the timing of the cell cycle clock) which
underscores the need not to assume that all aspects of
regeneration operate identically in all mammals.
The unique sensitivity of the human hepatocyte to TRAIL
(tumour necrosis factor-related apoptosis-inducing lig-
and) [11] likewise emphasises the need for caution when
extrapolating from rodent liver to human liver.
The vast majority of the literature concerns regeneration
in rats and mice and much less information is available
from human studies since the opportunity to study liver
regeneration in humans is generally limited to units spe-
cialising in liver surgery and is necessarily constrained by
ethical considerations. Surgical removal of liver metas-
tases affords the opportunity to obtain small samples ofComparative Hepatology 2004, 3:11 http://www.comparative-hepatology.com/content/3/1/11
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liver at the start, time of resection and time of wound clo-
sure approximating to the early sampling times in the ani-
mal studies. In this vein, the aim of the present study was
to determine whether very early increases in uPA activity
occur in the remnant liver following resection in man.
Results
The basal uPA activity associated with the membrane
preparations showed a wide patient to patient variation
ranging from 4 to 24 nmol/min/mg protein with a mean
of 9.94 nmol/min/mg protein (n = 18, SD = 5.06). This
variation in basal activity correlated neither with the age
of the patient – linear regression analysis gave a slope of -
0.03 and correlation analysis gave a Spearman coefficient
of -0.097 (p = 0.7), nor there was any difference between
the values for male patients (mean = 9.14 nmol/min/mg,
SD = 3.84, n = 7) and female patients (mean = 10.45, SD
= 5.83, n = 11) with a non-significant unpaired Student's
t test (p = 0.61).
The uPA activity associated with the membrane fractions
prepared from samples taken during the operation is
shown in Figure 1, for all the patients studied. The activity
of the final remnant fraction taken at the end of the oper-
ation was increased significantly above the activity of the
other fractions. The increased activity of the final remnant
fraction was, almost exclusively, confined to those
patients who had undergone a resection estimated at 50%
or greater (Figure 2A) and there was no increase in those
patients in whom the resection was less than 50% (Figure
2B). The percentage change in uPA activity as a function
of the resection size for the individual patients is shown in
Figure 2C. There was no correlation between uPA activity
and the size of the resection below about 50% resection,
but a positive correlation was observed when the resection
size was 50% or greater.
Figure 3 shows examples of the zymography gels confirm-
ing the presence in the membrane fractions of plasmino-
gen-dependent proteolytic activities. Minor bands in the
plasminogen-free control gel (indicating proteolysis
which was not plasminogen dependent) were occasion-
ally seen. The activity in these bands was always very
much less than the plasminogen dependent activities and
plasminogen-free gels had to be more extensively
destained in order to visualise these minor bands. Figures
3A and 3B show samples from a patient in whom the esti-
mated resection size was 60% and Figures 3C and 3D
show samples from a 15% resection. In both cases, major
bands corresponding to high molecular weight uPA and
tPA were clearly demonstrable in all the membrane frac-
tions together with minor bands of higher molecular
weight. The lanes in plasminogen-free control gel for the
patient with the major resection all showed a single very
faint band of approximately uniform intensity corre-
sponding to a protein larger than tPA (Figure 3A and 3B).
In Figure 3C, a high molecular weight band present only
in the lane corresponding to the remnant end sample
appeared with approximately equal intensity in the plas-
minogen-free gel (Figure 3D) indicating that this material
was not a plasminogen activator. Although the final rem-
nant sample in Fig 3A had increased uPA activity relative
to the other samples, as determined by the fluorometric
assay, the major bands of activity in the gel, correspond-
ing to the uPA and tPA markers, showed little change. In
our experience, this is a reflection of the qualitative nature
of the plasminogen activator zymography. We find that
with purified uPA and tPA proteins, an increase of about
one order of magnitude is necessary before the bands pro-
duced in the gels are notably different.
There were apparent increases in band size associated with
the higher molecular weight minor bands in the remnant
end sample. Although, at present, the precise nature of
these high molecular weight bands is uncertain, similar
high molecular weight plasminogen activators have been
previously reported [12,13]. The most logical explanation
would be an association with either uPAR or plasminogen
activator inhibitor type 1 (PAI-1), and on the basis of the
present observations such a complex is as likely to contain
tPA as uPA. These were not observed in the samples from
the patient with a smaller resection. At present, the
Membrane associated plasminogen activator activity (nmol/ min/mg protein) in the whole patient group Figure 1
Membrane associated plasminogen activator activity 
(nmol/min/mg protein) in the whole patient group. 
Samples were: Start (control sample taken at start of opera-
tion); 1 = Res 0; 2 = Rem 0; 3 = Res End; and 4 = Rem End, 
as described in the Methods. Values are means and the error 
bars are 95% confidence limits. Student's paired t test analysis 
showed the Start and Rem End samples to be statistically sig-
nificantly different (p = 0.01, n = 18). There were no statisti-
cal differences between start and any of the other samples.Comparative Hepatology 2004, 3:11 http://www.comparative-hepatology.com/content/3/1/11
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Membrane associated plasminogen activator activity (nmol/min/mg protein) in the group for whom the estimated resection size  was 50% or greater and for the group where the resection size was less than 50% Figure 2
Membrane associated plasminogen activator activity (nmol/min/mg protein) in the group for whom the esti-
mated resection size was 50% or greater and for the group where the resection size was less than 50%. Samples 
were: Start (control sample taken at start of operation); 1 = Res 0; 2 = Rem 0; 3 = Res End; and 4 = Rem End; as described in 
the Methods. Values are means and the error bars are 95% confidence limits. For the 50% and greater group (Figure 2A), Stu-
dent's paired t test analysis showed the Start and Rem End samples to be statistically significantly different (p = 0.002, n = 8). 
There were no statistical differences between start and any of the other samples. For the less than 50% group (Figure 2B), 
there were no statistical differences between any of the samples (n = 10). The relationship between increased uPA activity in 
the Rem End samples and extent of resection is shown in Figure 2C. There was no statistical correlation below 50% resection 
(Spearman correlation coefficient = -0.22, p = 0.268) but for 50% resection and higher a positive statistical correlation was 
observed (Spearman correlation coefficient = 0.67, p = 0.025, n = 9)
A
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biological significance of these changes in what appear to
be relatively minor bands is uncertain, but there was an
association with the large resection size and increased uPA
activity, as measured by fluorimetry.
Increases in uPA activity did not correlate with patient age
(Figure 4A) or the elapsed time interval between taking
the remnant start and the remnant end samples (Figure
4B). There was, however, a statistically significant negative
correlation between the increase in activity and the total
time for which the blood supply to the liver had been
clamped during the operative procedure (Figure 4C), sug-
gesting a link between increased proteolytic activity and
hepatic perfusion.
Discussion
Increased uPA activity and increased levels of uPAR are
among the earliest reported events in the remnant liver,
following 70% partial hepatectomy in rodents [5]. Since
then, several studies have emphasised the importance of
the plasminogen system to hepatocyte proliferation and
angiogenesis in the regenerating rodent liver [6-9]. We
have shown here for the first time in humans that
increases in plasminogen activator activity occur follow-
ing hepatectomy. Increased activity was only seen in rem-
nant liver at the end of the operative procedure when, at
least, 15 min had elapsed between the time at which the
resection was completed and the last remnant sample
taken, and where the magnitude of the resection was esti-
mated to be at least 50% of total liver volume. If, as pro-
posed by Mars et al. [5], increased uPA activity is an
essential feature at the start of regeneration, then these
observations confirm the findings of animal studies that
the magnitude of the regenerative response is dependent
on the extent of the hepatectomy [14,15]. The present
studies suggest that removal of, at least, half the liver mass
is necessary to generate the biological signal that results in
increased plasminogen activator activity.
The lack of any increase in uPA in response to resections
less than 50% compared to the positive correlation
between increased uPA activity and increased resection
Zymography gels for patients with greater than 50% resection and less then 50% resection Figure 3
Zymography gels for patients with greater than 50% resection and less then 50% resection. Figures 3A and 3B are 
greater than 50% and Figures 3C and 3D are less than 50%. The gels in Figures 3A and 3C contained plasminogen and the gels 
in Figures 3B and 3D are the corresponding plasminogen-free control gels. The samples run were, Lane 1- uPA (low molecular 
weight standard 33 kD, 0.6 ng); Lane 2- tPA standard (65 kD, 1 ng); Lane 3- uPA (high molecular weight standard 54 kD, 0.75 
ng); Lane 4–10 µl SeeBlue Plus2 pre-stained standard markers; Lanes 5–9 were washed membrane preparation (30 µg protein 
/ lane); Lane 5 – start; Lane 6 – Res 0; Lane 7 – Rem 0; Lane 8 – Res End; and Lane 9 – Rem End.Comparative Hepatology 2004, 3:11 http://www.comparative-hepatology.com/content/3/1/11
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Relationship between the increase in membrane associated uPA activity (nmol/min/mg protein) and (A) Age, (B) Elapsed time  between the time of the resection and the time at which the final sample was obtained, and (C) the total time for which the  portal vein was clamped during operation Figure 4
Relationship between the increase in membrane associated uPA activity (nmol/min/mg protein) and (A) Age, 
(B) Elapsed time between the time of the resection and the time at which the final sample was obtained, and 
(C) the total time for which the portal vein was clamped during operation. Spearman correlation analysis showed 
no correlation for A (p = 0.44, Spearman correlation coefficient = -0.071, n = 8), or B (p = 0.27, Spearman correlation coeffi-
cient = 0.26, n = 8). In C however, a statistically significant correlation was observed (p = 0.012, Spearman correlation coeffi-
cient = -0.89, n = 7).
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above 50% suggests a threshold event around the 40 to
50% level. The plot shown in Figure 2C bears a striking
resemblance to the data in the review by Bucher [14]
showing incorporation of tritiated thymidine into DNA
following hepatectomy in mature rats. A similar threshold
point at about 40% resection, with no correlation below
this level and a positive correlation above, was clearly
demonstrated in those studies also. The mechanism by
which resections greater than about 50% increasingly
result in elevated uPA activity and increased DNA synthe-
sis remains elusive. It is still unclear whether the same trig-
ger is responsible for the increases in both systems.
The possibility that the increased uPA activity seen here
represents a response to injury rather than an early regen-
erative response cannot be totally discounted. However,
in the rat partial hepatectomy model the anatomy allows
removal of the major liver lobe without imposing surgical
trauma on the remnant liver suggesting that increased uPA
activity is not injury related.
Zymography clearly showed several plasminogen activa-
tors to be associated with the membrane fractions. As
expected, the major bands corresponded to the high
molecular weight uPA and tPA markers. Although uPA
and its receptor uPAR have been implicated in the initia-
tion of the liver regeneration process [5,16], no similar
role has been ascribed to tPA. The latter binds to both liver
endothelial cells (via the mannose receptor) and hepato-
cytes (by the LDL receptor-related protein) as part of the
process by which tPA is rapidly cleared from the circula-
tion by the liver. To date, however, there is no evidence
from rodent studies to suggest that binding of tPA to
receptors is, in any way, involved in the response to hepa-
tectomy. However, the present study clearly shows tPA
activity associated with the liver membrane preparations,
and given the ability of tPA to generate active HGF in vitro
[1] the possibility of a role for tPA in the response of
human liver to partial hepatectomy needs to be borne in
mind. We also found several minor bands of higher
molecular weight, the nature of which is uncertain. These
could potentially represent larger forms of the plasmino-
gen activator or the plasminogen activator tightly bound
to some other protein. The most likely candidates for such
a complex would be uPA associating with either uPAR or
PAI-1. The final remnant sample obtained after major
resection showed increased amounts of these higher
molecular weight components. High molecular weight
forms of uPA have been observed in the rat prostate fol-
lowing castration [12] and also in cultured Kaposi sar-
coma cells [13]. In the latter, it was suggested that the high
molecular weight form of uPA contributed to the charac-
teristic hyperproliferative and invasive phenotype of the
Kaposi sarcoma lesions. Increased uPA activity associated
with increased metastatic activity seems well accepted and
uPA and other members of the urokinase plasminogen
activator system (including uPAR and PAI-1) have been
selected as novel targets for potential tumour therapies
[17]. Whether the high molecular weight forms of uPA are
also characteristic of an increased proliferative activity in
the liver remains to be fully established.
Presently, the source of the increased uPA activity is uncer-
tain. The very early increase in activity at 1 minute post-
hepatectomy in the rat and the lack of any associated
increase in mRNA for uPA, precludes any de novo protein
synthesis [5]. In the present study, the increased activity at
15 minutes post-resection also seems too rapid for a
mechanism requiring new protein synthesis. Mars et al.
[5] suggest that the increased uPA activity seen in rats
immediately following partial hepatectomy represents
binding of uPA from the blood to the uPA receptor in the
liver. The uPAR was undetectable on Western blots from
rat liver prior to hepatectomy, but was present in the rem-
nant liver as early as one minute post-hepatectomy and
increased in amount during the next 60 minutes. It has
been proposed that this increased uPAR binds uPA from
the circulating blood resulting in the increased uPA activ-
ity within the liver. The suggestion that this is a key ele-
ment in the initiation of the regeneration process
highlights the need for adequate perfusion of the liver.
Though the underlying molecular mechanisms remain
unclear, interruption of hepatic perfusion generally has
adverse effects on the regenerative response [4]. The
present study supports the hypothesis that continued liver
perfusion is important in the process by which increased
uPA activity is generated. Firstly, increases in uPA activity
did not occur in the liver that had been resected and
removed from the circulation; secondly, for those patients
in whom there was an increase in uPA activity, the magni-
tude of the increase was inversely related to the clamp
time, i.e., the longer the liver perfusion was interrupted
the smaller the response. Thus, in the present study,
increased uPA activity was negatively correlated with total
clamp time suggesting that hypoxia, which has been
shown to induce uPAR expression in cells in culture [18-
20], is not a likely mediator of the uPA increase seen here.
Finally, despite the proliferative capacity of hepatocytes
and the ability of the liver to regenerate declining with age
[14,15], we found no correlation between age and basal
uPA activity and the increase in remnant liver uPA activity
was also not age dependent.
Conclusions
In the present paper, we show early increases in uPA activ-
ity can be demonstrated in the remnant liver following
resection of metastatic tumours in patients in whom the
resection was estimated to be 50% or greater. To the best
of our knowledge this is the first time this has beenComparative Hepatology 2004, 3:11 http://www.comparative-hepatology.com/content/3/1/11
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demonstrated. Such increases are amongst the earliest
events following hepatectomy in rats, where they are con-
sidered to initiate changes in the extracellular matrix
essential for subsequent hepatocyte division. Thus, our
results support a similar role in the initiation of liver
regeneration in man.
Methods
Patients
The South Sheffield Research Ethics Committee approved
the research protocol and fully informed consent was
obtained. Eighteen patients undergoing partial hepatec-
tomy for the removal of hepatic metastases secondary to
primary colonic tumours were studied. There were 7
males and 11 females with an age range from 24 to 78
years (median 67.5).
Operative Procedure
Standard operative procedures were followed. The liver
was mobilised and the resection delineated with dia-
thermy. The portal inflow was clamped while resection
with an ultrasonic dissector was carried out. Typically, the
portal inflow was released every 15 minutes for 5 minutes
intervals to prevent ischaemic damage and the total
clamping time was recorded. Resection margins were sent
separately for histopathology. The magnitude of the resec-
tion was estimated as percentage of the total liver volume,
by the surgeon.
The following samples were taken from tumour-free
regions of the liver during the operation. A sample was
obtained before the resection was started (this was
labelled 'Start'). Immediately following resection samples
were taken from the remnant liver (labelled 'Rem 0' for
remnant liver at time 0) and from the resected liver as far
away from the tumour as possible (labelled 'Res 0' for
resected liver at time 0). The samples were placed in cryo-
vials and immediately frozen in liquid nitrogen in the
operating theatre. A second sample of the resected liver
(labelled 'Res end') was kept at room temperature until
the end of the operative procedure and was only trans-
ferred to liquid nitrogen when the final sample from the
remnant liver was taken. The final sample ('Rem end' for
remnant end) was taken from the remnant liver as late
into the operation as possible and frozen immediately.
The 'Res end' sample was also frozen at this time. The
interval between the time of sampling 'Rem 0' and 'Rem
end' ranged from 7 to 90 minutes. The median was 20.5
minutes and 15 of the 18 intervals were between 10 and
33 minutes. Samples were stored in liquid nitrogen in the
laboratory and only thawed immediately prior to analysis.
Materials
Casein, plasminogen, uPA (high and low molecular
weight forms) and tPA were purchased from Calbiochem
(CN Biosciences Ltd., UK). The fluorometric substrates 7-
amino-4-methylcoumarin (AMC), Z-Gly-Gly-Arg-AMC
and EGR-CMK (Glu-Gly-Arg-Chloromethylketone) were
from Bachem Ltd. (UK). Electrophoresis reagents were
from BioRad and Geneflow Ltd. Other reagents were from
Sigma-Aldrich Co Ltd. (Poole, UK).
Sample preparation
Liver samples were homogenised in a ten-fold volume of
homogenisation buffer: 250 mM sucrose / 10 mM MOPS
pH 7.4 containing the protease inhibitors E-64 (20 µM),
Pepstatin A (20 µM), and EDTA (0.2 mM). Inhibitors
against the serine proteases, which include uPA, were not
included.
Membrane preparation
A membrane preparation was made by differential centrif-
ugation of the homogenate in a TLS 55 swinging bucket
rotor in a Beckman TL-100 bench top ultracentrifuge
(Beckman Coulter Ltd., High Wycombe, UK). The
homogenate was initially centrifuged at 40,000 g, for 20
minutes, to pellet large cell organelles such as nuclei and
mitochondria. After centrifugation the fat at the top of
each tube was removed with a piece of tissue and the
supernatants transferred to clean tubes and recentrifuged
at 105,000 g, for 1 hour. The membranous pellets were
then washed twice by resuspending in homogenisation
buffer and recentrifuged at 105,000 g, for 1 hour. All cen-
trifugations were carried out at 4°C.
The protein content of the homogenates and membrane
preparations was determined by the BCA (bicinchoninic
acid) method [21] using a kit from Sigma-Aldrich.
uPA fluorometric assay
uPA activity was determined by a fluorimetric continuous
rate assay of Z-Gly-Gly-Arg-AMC hydrolysis using a Perkin
Elmer LS50B fluorimeter linked to an IBM compatible
computer running the FLUSYS software [22]. Cleavage at
the Gly-Arg bond by uPA releases the AMC from its
quenched state [23] and the rate at which fluorescence is
produced taken as a measure of uPA activity.
At the end of the assay, EGR-CMK (Glu-Gly-Arg-Chlo-
romethylketone), a chemical inhibitor of uPA, was added
to check that this compound inhibited the measured
activity. Any activity still persisting was taken as not uPA-
mediated and subtracted from the rate measured in the
absence of EGR-CMK.
Since the biologically relevant fraction of uPA is generally
considered to be associated with its receptor uPAR and
therefore localised to the cell membrane, uPA activity
measurements were performed with washed membrane
preparations rather than with total liver homogenates.Comparative Hepatology 2004, 3:11 http://www.comparative-hepatology.com/content/3/1/11
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Preliminary experiments demonstrated the necessary lin-
ear response between the measured activity and the vol-
ume of membrane preparation assayed (data not shown).
All samples were assayed in triplicate at two sample vol-
umes to ensure linearity of activity with amount of extract.
The measured rates were then adjusted for the protein
concentration of each sample to give a rate in nmoles/
min/mg of protein.
Zymography
Zymography was carried out with 7.5% SDS PAGE two-
substrate gels essentially as described by Bryson et al. [24].
The control, plasminogen-free, gels contained casein
alone (final concentration of 6 mg/ml gel) and the test
gels contained plasminogen at a final concentration of 9.3
µg (1.12 U) / ml gel in addition to the casein. Following
electrophoresis gels were washed in 25% (v/v) Triton X-
100, for 1 hour at room temperature, and then in 50 mM
Tris (pH 7.6) for 16–20 hours and at 37°C, prior to stain-
ing with Coomassie blue. Purified uPA (high molecular
weight and low molecular weight) and tPA (all from Cal-
Biochem, CN Biosciences Ltd., Nottingham UK) and See-
Blue Plus2 Pre-stained standards (Invitrogen Life
Technologies, Paisley, UK) were included on each gel as
markers.
Graph plotting and statistical analysis
All Figures were generated and analysed with the Graph-
Pad Prism package (version 3.0). Statistical analyses (Stu-
dent's  t  tests, simple linear regression, Spearman
correlations) were performed using the software in the
cited package.
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